• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖凝集素-3:一种可能作为前列腺特异性抗原血液检测补充标志物的物质。

Galectin-3: a possible complementary marker to the PSA blood test.

作者信息

Balan Vitaly, Wang Yi, Nangia-Makker Pratima, Kho Dhonghyo, Bajaj Madhuri, Smith Daryn, Heilbrun Lance, Raz Avraham, Heath Elisabeth

机构信息

Department of Oncology and 2 Biostatistics Core Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.

出版信息

Oncotarget. 2013 Apr;4(4):542-9. doi: 10.18632/oncotarget.923.

DOI:10.18632/oncotarget.923
PMID:23625538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3720602/
Abstract

The prostate-specific antigen (PSA) test has served as a blood marker of prostate cancer (PCa), and for monitoring recurrence/metastasis in patients after therapeutic intervention. However, the applicability/reliability of the PSA test was recently questioned as it is not without challenges, in particular in men who have PCa without an elevated PSA (false negative), or in men who are disease-free with elevated levels of PSA (false positive). Galectin-3 is a tumor-associated protein; present in the seminal fluid and is a substrate for the PSA enzyme e.g., a chymotrypsin-like serine protease. We hypothesized that the cleavage status and level of galectin-3 in the prostate tissue and sera are associated with PCa. Thus, we compared galectin-3 levels obtained from sera of non-cancer urology patients to those of metastatic PCa patients. The data were confirmed by analyzing PCa tissue arrays. Here, we report that galectin-3 levels in the sera of patients with metastatic PCa were uniformly higher as compared to the non-cancer patient controls. The data suggest that galectin-3 serum level may be a useful serum complementary marker to the PSA blood test to be used for initial and follow-up PSA complimentary diagnostic/prognostic tool for recurrence in PCa patients.

摘要

前列腺特异性抗原(PSA)检测一直作为前列腺癌(PCa)的血液标志物,并用于监测接受治疗干预后患者的复发/转移情况。然而,PSA检测的适用性/可靠性最近受到质疑,因为它并非没有挑战,特别是在患有前列腺癌但PSA未升高的男性(假阴性),或在无疾病但PSA水平升高的男性(假阳性)中。半乳糖凝集素-3是一种肿瘤相关蛋白;存在于精液中,是PSA酶(例如一种胰凝乳蛋白酶样丝氨酸蛋白酶)的底物。我们假设前列腺组织和血清中半乳糖凝集素-3的裂解状态和水平与前列腺癌有关。因此,我们比较了非癌泌尿外科患者血清与转移性前列腺癌患者血清中半乳糖凝集素-3的水平。通过分析前列腺癌组织阵列证实了这些数据。在此,我们报告转移性前列腺癌患者血清中的半乳糖凝集素-3水平与非癌患者对照组相比一致更高。数据表明,半乳糖凝集素-3血清水平可能是PSA血液检测的一种有用的血清补充标志物,可用于前列腺癌患者复发的初始和随访PSA补充诊断/预后工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/72eac3b71ac1/oncotarget-04-542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/6ad7c55b42ec/oncotarget-04-542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/bb042efab827/oncotarget-04-542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/a05af056cc34/oncotarget-04-542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/72eac3b71ac1/oncotarget-04-542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/6ad7c55b42ec/oncotarget-04-542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/bb042efab827/oncotarget-04-542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/a05af056cc34/oncotarget-04-542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d9/3720602/72eac3b71ac1/oncotarget-04-542-g004.jpg

相似文献

1
Galectin-3: a possible complementary marker to the PSA blood test.半乳糖凝集素-3:一种可能作为前列腺特异性抗原血液检测补充标志物的物质。
Oncotarget. 2013 Apr;4(4):542-9. doi: 10.18632/oncotarget.923.
2
Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I.前列腺癌患者中半乳糖凝集素-3与前列腺特异性抗原水平之间的正相关关系:一项前瞻性临床研究-I
Oncotarget. 2016 Dec 13;7(50):82266-82272. doi: 10.18632/oncotarget.12619.
3
The influence of PSA autoantibodies in prostate cancer patients: a prospective clinical study-II.前列腺癌患者中前列腺特异性抗原自身抗体的影响:一项前瞻性临床研究-II。
Oncotarget. 2017 Mar 14;8(11):17643-17650. doi: 10.18632/oncotarget.12620.
4
Prevelance of prostate cancer among Turkish men with prostate-specific antigen level of ≤100 ng/ml.前列腺特异性抗原水平≤100 ng/ml的土耳其男性中前列腺癌的患病率。
J Cancer Res Ther. 2018 Oct-Dec;14(6):1256-1259. doi: 10.4103/0973-1482.187387.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.紫藤凝集素及其携带反应性聚糖的前列腺特异性抗原作为前列腺癌的新型诊断和预后标志物
Int J Mol Sci. 2017 Jan 26;18(2):261. doi: 10.3390/ijms18020261.
7
Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer.前列腺癌抗原 3 与前列腺特异性抗原联合检测可提高前列腺癌高危人群的诊断准确性。
Arch Pathol Lab Med. 2018 Sep;142(9):1106-1112. doi: 10.5858/arpa.2017-0185-OA. Epub 2018 Mar 16.
8
[Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].[前列腺特异性抗原在确定初次前列腺活检指征中的预后意义]
Urologiia. 2018 Jul(3):92-97.
9
Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer.循环中网膜素、瘦素、VEGF 和 HGF 的水平及其与前列腺癌 PSA 标志物的临床相关性。
Dis Markers. 2018 Aug 16;2018:3852401. doi: 10.1155/2018/3852401. eCollection 2018.
10
[PSA and hK2 in the diagnosis of prostate cancer].[前列腺特异性抗原和人激肽释放酶2在前列腺癌诊断中的应用]
Actas Urol Esp. 2008 Jun;32(6):575-88. doi: 10.1016/s0210-4806(08)73891-9.

引用本文的文献

1
Evaluation of serum galectin-3 concentration as a potential biomarker in exudative-type age-related macular degeneration.评估血清半乳糖凝集素-3浓度作为渗出型年龄相关性黄斑变性潜在生物标志物的作用。
Sci Rep. 2024 Dec 30;14(1):31957. doi: 10.1038/s41598-024-83499-w.
2
Biomarkers in Cancer Detection, Diagnosis, and Prognosis.癌症检测、诊断和预后中的生物标志物。
Sensors (Basel). 2023 Dec 20;24(1):37. doi: 10.3390/s24010037.
3
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer.

本文引用的文献

1
Galectins as cancer biomarkers.半乳糖凝集素作为癌症生物标志物。
Cancers (Basel). 2010 Apr 20;2(2):592-610. doi: 10.3390/cancers2020592.
2
Identification of miR-30d as a novel prognostic maker of prostate cancer.鉴定miR-30d作为前列腺癌一种新的预后标志物。
Oncotarget. 2012 Nov;3(11):1455-71. doi: 10.18632/oncotarget.696.
3
Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients.同时测定血清半乳糖凝集素-3 和 -4 水平可检测结直肠癌患者的转移。
循环免疫蛋白:改善晚期非小细胞肺癌的诊断和临床结局。
Int J Mol Sci. 2023 Dec 18;24(24):17587. doi: 10.3390/ijms242417587.
4
Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor.Galectin-3 和雌激素受体对前列腺癌的分子调控。
Front Endocrinol (Lausanne). 2023 Mar 3;14:1124111. doi: 10.3389/fendo.2023.1124111. eCollection 2023.
5
Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?半乳糖凝集素-3 在前列腺癌和心脏病中的作用:这两种可怕疾病的生物标志物?
Mol Biol Rep. 2023 Mar;50(3):2763-2778. doi: 10.1007/s11033-022-08207-1. Epub 2022 Dec 30.
6
Use of Glycoproteins-Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer.糖蛋白-前列腺特异性膜抗原和半乳糖凝集素-3作为转移性前列腺癌管理中的原发性肿瘤标志物和治疗靶点的应用。
Cancers (Basel). 2022 May 30;14(11):2704. doi: 10.3390/cancers14112704.
7
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.半乳糖凝集素-3 在前列腺癌干细胞样细胞中具有免疫抑制作用,并促进早期转移。
Front Immunol. 2020 Sep 10;11:1820. doi: 10.3389/fimmu.2020.01820. eCollection 2020.
8
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.基于肝癌微环境构建风险评分预后模型。
World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134.
9
Extracellular galectin-3 facilitates colon cancer cell migration and is related to the epidermal growth factor receptor.细胞外半乳糖凝集素-3促进结肠癌细胞迁移,并与表皮生长因子受体相关。
Am J Transl Res. 2018 Aug 15;10(8):2402-2412. eCollection 2018.
10
Galectin-3 Serum Levels Could Help Clinicians Screen for Salivary Gland Tumor Patients.半乳糖凝集素-3血清水平有助于临床医生筛查涎腺肿瘤患者。
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):689-692. doi: 10.22034/APJCP.2018.19.3.689.
Cell Oncol (Dordr). 2013 Feb;36(1):9-13. doi: 10.1007/s13402-012-0109-1. Epub 2012 Nov 2.
4
Ligand induced galectin-3 protein self-association.配体诱导半乳糖凝集素-3 蛋白自组装。
J Biol Chem. 2012 Jun 22;287(26):21751-6. doi: 10.1074/jbc.C112.358002. Epub 2012 May 1.
5
The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.组织和血清半乳糖凝集素-3 在胰腺癌中的表达及临床意义。
J Cancer Res Clin Oncol. 2012 Jun;138(6):1035-43. doi: 10.1007/s00432-012-1178-2. Epub 2012 Feb 25.
6
Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage.酪氨酸磷酸化半乳糖凝集素 3 蛋白对前列腺特异性抗原 (PSA) 的裂解具有抗性。
J Biol Chem. 2012 Feb 17;287(8):5192-8. doi: 10.1074/jbc.C111.331686. Epub 2012 Jan 9.
7
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).一种制备前列腺特异性膜抗原(PSMA)多价抑制剂的模块化策略。
Oncotarget. 2011 Dec;2(12):1244-53. doi: 10.18632/oncotarget.415.
8
Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathway.通过非致死性渗透孔释放蛋白质作为一种替代性非经典分泌途径。
BMC Cell Biol. 2011 Oct 18;12:46. doi: 10.1186/1471-2121-12-46.
9
Galectin-3--a jack-of-all-trades in cancer.半乳糖凝集素-3——癌症中的多面手。
Cancer Lett. 2011 Dec 27;313(2):123-8. doi: 10.1016/j.canlet.2011.09.003. Epub 2011 Sep 17.
10
Association of Mycoplasma hominis infection with prostate cancer.人型支原体感染与前列腺癌的关联。
Oncotarget. 2011 Apr;2(4):289-97. doi: 10.18632/oncotarget.256.